Vascular Sensitivity to Adrenergic Agonists in Patients With CHF and in Healthy Subjects

NCT00782782 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2008-10-31

No results posted yet for this study

Summary

Congestive Heart failure (CHF) is asociated with changes in cardiac function and vascular responses. The aim of this study is to characterize these differences. Our hypothesis is, that there are differences in vascular responses between healthy subjects and patients with CHF.

Conditions

  • Congestive Heart Failure

Sponsors & Collaborators

  • Hadassah Medical Organization

    lead OTHER

Principal Investigators

  • Mordechai Muszkat · Hadassah University Hospital

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2009-12-31
Completion
2011-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00782782 on ClinicalTrials.gov